tiprankstipranks
Trending News
More News >
HOYA CORPORATION (JP:7741)
:7741

HOYA (7741) AI Stock Analysis

Compare
8 Followers

Top Page

JP:7741

HOYA

(7741)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
¥26,561.00
▲(11.65% Upside)
HOYA's strong financial performance is the most significant factor, supported by robust profitability and financial stability. Technical analysis indicates a positive trend, though valuation concerns due to a high P/E ratio slightly offset the overall score. The absence of earnings call and corporate events data limits additional insights.
Positive Factors
Revenue Growth
Consistent revenue growth in both healthcare and electronics segments indicates strong market demand and effective business strategy.
Cash Generation
Strong cash generation capabilities provide HOYA with the flexibility to invest in growth opportunities and maintain financial stability.
Balance Sheet Health
Low leverage and a strong equity ratio reflect prudent financial management, reducing risk and enhancing long-term stability.
Negative Factors
Cash Conversion Efficiency
While cash generation is strong, improving cash conversion efficiency could enhance liquidity and operational flexibility.
Valuation Concerns
High valuation may limit investor interest and pose challenges in maintaining stock price stability if growth expectations are not met.
Dividend Yield
A low dividend yield may deter income-focused investors, potentially impacting shareholder base diversity and stock attractiveness.

HOYA (7741) vs. iShares MSCI Japan ETF (EWJ)

HOYA Business Overview & Revenue Model

Company DescriptionHOYA Corporation (7741) is a Japanese multinational company known for its diverse portfolio in the fields of healthcare, optics, and electronics. The company primarily operates through two segments: the Healthcare segment, which includes the production of medical devices, eye care products, and pharmaceuticals, and the Electronics segment, which focuses on the manufacturing of advanced semiconductor and display materials. HOYA's core products include intraocular lenses, contact lenses, and optical glass, as well as photomasks and other materials used in semiconductor manufacturing.
How the Company Makes MoneyHOYA generates revenue through multiple key streams. The Healthcare segment contributes significantly by selling intraocular lenses and surgical instruments for cataract surgery, as well as a variety of eyeglass lenses and contact lenses. Revenue in this sector is bolstered by ongoing demand for vision correction products and an aging population. The Electronics segment generates income by supplying photomasks and other critical materials used in semiconductor fabrication, catering to major tech companies in the electronics industry. Strategic partnerships with leading semiconductor manufacturers and healthcare providers enhance HOYA's market presence and revenue opportunities. Additionally, the company invests in research and development to innovate and expand its product offerings, further driving growth and profitability.

HOYA Financial Statement Overview

Summary
HOYA's financial performance is robust, characterized by strong profitability, a solid balance sheet, and healthy cash flows. The company exhibits impressive revenue growth and efficient operations, with minimal financial leverage. While the slight decline in gross profit margin and slowing cash flow growth warrant monitoring, the overall financial health remains strong, positioning HOYA well for future growth and stability.
Income Statement
85
Very Positive
HOYA demonstrates strong profitability with a high gross profit margin of 73.91% and a solid net profit margin of 23.34% in the TTM. The company has shown impressive revenue growth, particularly in the TTM with a 76.6% increase, indicating robust demand for its products. EBIT and EBITDA margins are also healthy, reflecting efficient operations. However, the slight decline in gross profit margin from the previous year suggests potential cost pressures.
Balance Sheet
80
Positive
HOYA maintains a strong balance sheet with a low debt-to-equity ratio of 0.038, indicating minimal leverage and financial risk. The return on equity is robust at 20.39%, showcasing effective use of shareholder funds to generate profits. The equity ratio is healthy, suggesting a stable financial structure. Overall, the balance sheet reflects financial stability and low risk.
Cash Flow
78
Positive
The cash flow statement reveals strong cash generation capabilities, with a free cash flow to net income ratio of 79.62% and a consistent operating cash flow coverage ratio. The free cash flow growth rate of 3.02% in the TTM indicates steady cash flow improvements. However, the growth rate has slowed compared to previous periods, which could be a point of concern if it continues.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue892.50B866.03B762.61B723.58B661.47B547.92B
Gross Profit715.03B693.58B606.30B567.05B511.05B424.21B
EBITDA325.28B309.48B284.45B266.20B254.48B196.57B
Net Income209.28B202.10B181.38B168.64B164.51B125.45B
Balance Sheet
Total Assets1.28T1.23T1.20T1.03T992.84B853.29B
Cash, Cash Equivalents and Short-Term Investments596.39B533.97B525.16B405.89B419.40B334.90B
Total Debt41.54B37.28B29.24B24.58B21.60B20.75B
Total Liabilities280.48B262.65B241.36B213.72B203.78B180.88B
Stockholders Equity1.01T974.02B967.76B818.32B803.85B688.00B
Cash Flow
Free Cash Flow194.43B187.19B181.73B168.36B161.18B120.57B
Operating Cash Flow247.05B235.11B222.80B201.83B190.06B151.81B
Investing Cash Flow-15.10B-35.82B-35.81B-39.93B-29.13B-29.79B
Financing Cash Flow-202.51B-187.72B-110.89B-202.16B-106.89B-115.67B

HOYA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price23790.00
Price Trends
50DMA
23522.80
Positive
100DMA
21621.06
Positive
200DMA
19286.31
Positive
Market Momentum
MACD
112.13
Negative
RSI
52.08
Neutral
STOCH
60.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7741, the sentiment is Positive. The current price of 23790 is above the 20-day moving average (MA) of 23554.00, above the 50-day MA of 23522.80, and above the 200-day MA of 19286.31, indicating a bullish trend. The MACD of 112.13 indicates Negative momentum. The RSI at 52.08 is Neutral, neither overbought nor oversold. The STOCH value of 60.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7741.

HOYA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥8.22T39.4720.74%1.00%8.83%8.63%
72
Outperform
¥2.21T23.1513.13%1.00%0.42%34.76%
68
Neutral
¥3.42T26.179.31%1.21%7.68%10.08%
68
Neutral
¥790.80B52.9310.09%0.81%13.53%-7.39%
62
Neutral
¥239.51B22.004.38%2.05%6.04%733.13%
61
Neutral
¥951.00B20.379.80%1.95%1.51%-12.59%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7741
HOYA
23,790.00
3,804.83
19.04%
JP:4543
Terumo
2,313.00
-700.45
-23.24%
JP:7747
Asahi Intecc Co
3,008.00
528.16
21.30%
JP:8086
Nipro
1,462.00
38.73
2.72%
JP:7733
Olympus
1,997.50
-305.45
-13.26%
JP:6869
Sysmex
1,522.50
-1,371.52
-47.39%

HOYA Corporate Events

HOYA Corporation Concludes Share Repurchase Plan
Dec 5, 2025

HOYA Corporation announced the completion and termination of its share repurchase plan, which was initially resolved by the Board of Directors on August 21, 2025. The company repurchased a total of 4,708,300 shares, amounting to approximately 99.999 billion yen, through market purchases on the Tokyo Stock Exchange, reflecting a strategic move to enhance shareholder value.

HOYA Corporation Updates on Share Repurchase Program
Dec 1, 2025

HOYA Corporation announced the status of its ongoing share repurchase program, which was initially resolved by the Board of Directors in August 2025. As of November 30, 2025, the company has repurchased 4,650,000 shares, spending a total of 98,658,475,500 yen, with a maximum target of 6.2 million shares by January 2026. This strategic move is part of HOYA’s efforts to enhance shareholder value and optimize its capital structure.

HOYA Corporation to Restructure Contact Lens Business
Nov 5, 2025

HOYA Corporation announced a strategic move to transfer its contact lens retail business to a newly formed subsidiary, HOYA Eye Care Retailing Corporation, effective April 1, 2026. This decision aims to enhance business operations by allowing for more focused sales, marketing, and store management strategies tailored to the contact lens industry, potentially improving market positioning and operational efficiency.

HOYA Corporation Updates on Share Repurchase Progress
Nov 4, 2025

HOYA Corporation announced the status of its ongoing share repurchase plan, which was resolved by the Board of Directors in August 2025. As of October 31, 2025, the company repurchased 2,022,600 shares for approximately 44.56 billion yen, as part of a larger plan to buy back up to 6.2 million shares. This strategic move is likely to impact the company’s stock value and shareholder returns, reflecting HOYA’s commitment to enhancing shareholder value.

HOYA Corporation Announces Significant Interim Dividend Increase
Oct 31, 2025

HOYA Corporation announced an interim dividend of 125 yen per share for the fiscal year ending March 31, 2026, marking a significant increase from the previous year’s interim dividend. This decision reflects HOYA’s strategy to enhance corporate value by balancing growth investments with shareholder returns, while maintaining financial soundness and capital efficiency.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025